Active pharmaceutical ingredient
In the pharmaceutical market: The pharmaceutically effective component of a drug (also API).
Adalimumab is the first entirely human monoclonal antibody (against the tumor necrosis factor , TNF ). Adalimumab is used for the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and Crohn’s disease.
German Pharmaceutical Market Restructuring Act, which became effective as of January 1, 2011.
Permission under drug laws to market a drug in a national market.
In the pharmaceutical market: control of equipment and documentation of manufacturers or their suppliers.
Economic Optimization of Pharmaceutical Care Act; took effect in Germany on May 1, 2006.